KALBERMATTEN ADAM R 4

4 · KORU Medical Systems, Inc. · Filed Mar 18, 2026

AI-generated summary of this filing

Updated Mar 18, 2026

KORU (KRMD) President Adam Kalbermatten Receives Equity Award

What Happened

Adam R. Kalbermatten, President-Chief Commercial Officer of KORU Medical Systems (KRMD), received three equity awards on 2026-03-17 totaling 157,975 units (45,098; 45,098; and 67,779). Each unit represents a right to receive one share of common stock. All awards were granted at $0.00 (derivative awards), so no cash was paid by the insider.

Key Details

Transaction date: 2026-03-17; Form 4 filed 2026-03-18 (appears timely).
Grants: 45,098 units; 45,098 units; 67,779 units — total 157,975 units; reported price $0.00 (derivative awards).
Shares owned after transaction: not specified in the summary filing.
Vesting and performance notes:
- F1: Each unit = right to one common share on applicable vesting date.
- F2: Some units vest in equal increments on March 17, 2027 and each of the next three anniversaries.
- F3: Certain units vest only if performance targets are met as of Dec 31, 2028; reported amount is the target (0%–150% payout range). Those performance units vest at 100% upon a change in control before 12/31/2028.
Filing remark: includes standard disclaimer that the filer is not necessarily admitting beneficial ownership; Power of Attorney previously filed.

Context

These are grant/award (derivative) transactions, not open-market purchases or sales — they do not generate immediate cash for the insider nor indicate an immediate sale of shares. Performance-based components mean the final number of shares earned could be higher or lower than the target reported. Such awards are commonly used for retention and incentive compensation; they should be interpreted as part of executive pay rather than a direct market bet.

Form 4

Period: 2026-03-17

President-Chief Commercial Off

Transactions

Award
Restricted Stock Unit
[F1][F2]
2026-03-17+45,098→ 45,098 total
→ Common Stock (45,098 underlying)
Award
Performance Stock Unit
[F1][F3]
2026-03-17+45,098→ 45,098 total
→ Common Stock (45,098 underlying)
Award
Option to buy Common Stock
[F2]
2026-03-17+67,779→ 67,779 total
Exercise: $4.35Exp: 2036-03-17→ Common Stock (67,779 underlying)

Footnotes (3)

[F1]Each unit represents a right to receive one share of common stock underlying the vested award on the applicable vesting date.
[F2]The units comprising the award vest in equal increments on March 17, 2027 and each first, second and third anniversaries thereof (each, a vesting date).
[F3]These units will vest based upon the achievement of certain performance conditions as of December 31, 2028. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-150% of the amount reported depending on the level of performance achieved. These units will vest at 100% of the amount reported upon a change in control of the Company prior to December 31, 2028.

Signature

/s/ Thomas Adams - Attorney-in-Fact|2026-03-18

1 file